Medical Condition News

RSS

AI could lead to better ways to predict the onset and course of cardiovascular disease

For the first time, University of Utah Health scientists have shown that artificial intelligence could lead to better ways to predict the onset and course of cardiovascular disease.

20 Jan 2022

MD Anderson and Yingli Pharma announce strategic alliance to advance many oncology programs

The University of Texas MD Anderson Cancer Center and Yingli Pharma US, Inc. today announced a strategic alliance to advance several oncology programs from preclinical discovery through clinical development.

20 Jan 2022

Intense, regular walking may help prevent Type 2 diabetes among 70 and 80 year olds

Walking regularly and at greater intensity may help prevent Type 2 diabetes among 70 and 80 year olds, according to one of the first studies measuring steps and pace among this population.

20 Jan 2022

Could heart rate be a risk factor for dementia?

In this interview, we speak to Dr. Yume Imahori about her latest research which looks at whether heart rate could be used as an early risk factor for dementia.

20 Jan 2022

Scientists explore the possibility of Omicron ending the COVID-19 pandemic

A new analysis parses out what scientists currently know about the Delta variant and predicts what the end of the COVID-19 pandemic might look like.

20 Jan 2022

Recombinant bat coronavirus reported in wide-ranging Cambodian bat

A new study reports on the detection of recombinant coronaviruses in several bat species in Cambodia and of a related species in China.

20 Jan 2022

Exploring the potential utility of calcium channel inhibitors in SARS-CoV-2 infection

In a new study, researchers discuss the role of calcium signaling pathways as targets of inhibition in potential new antiviral therapeutic pathways for SARS-CoV-2.

20 Jan 2022

Eikonoklastes completes a license to add novel gene therapy for treating neurodegenerative diseases

Eikonoklastes Therapeutics, a preclinical stage biopharmaceutical company, today announced it has completed a license with the University of California San Diego to add a novel gene therapy for the treatment of neurodegenerative diseases.

20 Jan 2022

Environmental risk factors driving the nearsightedness 'epidemic' in the UK

A team of researchers used the UK Biobank Study to investigate whether changing environmental factors are causing an increase in myopia.

20 Jan 2022

SARS-CoV-2 Omicron infections milder in children compared to Delta

The clinical severity of COVID-19 was found to be lower in children younger than five years of age after the emergence of SARS-CoV-2 Omicron variant.

20 Jan 2022

Researchers compare two psychotherapies used for treating veterans with PTSD

Cognitive processing therapy and prolonged exposure are the two leading trauma-focused cognitive behavioral psychotherapies used for Veterans Affairs patients with PTSD.

20 Jan 2022

Newly developed gene therapy can treat a severe form of epilepsy and prolong survival

Research from the University of Virginia School of Medicine suggests how a newly developed gene therapy can treat Dravet syndrome, a severe form of epilepsy, and potentially prolong survival for people with the condition.

20 Jan 2022

Females more prone to long-term post-COVID-19 symptoms

In a recent study published in the Journal of Clinical Medicine, researchers described the results of a multi-center study (LONG-COVID-EXP-CM) that investigated sex differences in coronavirus disease 2019 (COVID-19)-related symptoms and long-term post-COVID-19 symptoms in a group of previously hospitalized COVID-19 survivors in a large Spanish population.

19 Jan 2022

Variants of SARS-CoV-2 and preventive strategies

A recent review article published in the journal Advanced Science reviewed the features of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and its variants. Using a physical and materials science perspective, the review also summarizes the most significant variants of SARS-CoV-2 encountered to date as well as possible preventive strategies.

19 Jan 2022

How does SARS-CoV-2 infection impact female fertility?

In a recent study published in the journal International Journal of Environmental Research and Public Health, a team of researchers reviewed published literature that assessed the effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on female reproductive health.

19 Jan 2022

SARS-CoV-2 RNA can be detected in exhaled aerosol

In a study published in the open-access journal Influenza and other Respiratory Viruses, researchers investigated if severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can be detected in exhaled aerosol samples obtained from coronavirus disease 2019 (COVID-19) patients during many different types of breathing and coughing. They also analyzed how SARS-CoV-2 infection may affect the size and number of exhaled aerosol particles.

19 Jan 2022

Treatment with immune-boosting protein and radiation improves survival in mice with glioblastoma

Glioblastoma, an aggressive cancer in the brain or spinal cord, has proven stubbornly resistant to newer immunotherapies. And radiation and chemotherapy, the standard treatment for glioblastoma, result in fewer than 10% of patients surviving longer than five years after diagnosis.

19 Jan 2022

Researchers develop nanotherapeutic drug to prevent cancer from spreading to the liver

Physician researchers from UT Southwestern Medical Center have developed an innovative nanotherapeutic drug that prevents cancer from spreading to the liver in mice.

19 Jan 2022

Oral penicillin may be a safer option for people with high-risk rheumatic heart disease

A growing body of evidence indicates that some people thought to have an allergic response to injectable penicillin, the standard treatment for rheumatic heart disease, may instead be experiencing a cardiac reaction to the medicine, according to a new American Heart Association presidential advisory published today in Journal of the American Heart Association.

19 Jan 2022

Scientists reveal toxic astrocyte changes in ALS

Scientists at the Francis Crick Institute have revealed harmful changes in supporting cells, called astrocytes, in Amyotrophic Lateral Sclerosis (ALS) in two publications in Brain and Genome Research.

19 Jan 2022

Medical Condition News

AI could lead to better ways to predict the onset and course of cardiovascular disease

MD Anderson and Yingli Pharma announce strategic alliance to advance many oncology programs

Intense, regular walking may help prevent Type 2 diabetes among 70 and 80 year olds

Could heart rate be a risk factor for dementia?

Scientists explore the possibility of Omicron ending the COVID-19 pandemic

Recombinant bat coronavirus reported in wide-ranging Cambodian bat

Exploring the potential utility of calcium channel inhibitors in SARS-CoV-2 infection

Eikonoklastes completes a license to add novel gene therapy for treating neurodegenerative diseases

Environmental risk factors driving the nearsightedness 'epidemic' in the UK

SARS-CoV-2 Omicron infections milder in children compared to Delta

Researchers compare two psychotherapies used for treating veterans with PTSD

Newly developed gene therapy can treat a severe form of epilepsy and prolong survival

Females more prone to long-term post-COVID-19 symptoms

Variants of SARS-CoV-2 and preventive strategies

How does SARS-CoV-2 infection impact female fertility?

SARS-CoV-2 RNA can be detected in exhaled aerosol

Treatment with immune-boosting protein and radiation improves survival in mice with glioblastoma

Researchers develop nanotherapeutic drug to prevent cancer from spreading to the liver

Oral penicillin may be a safer option for people with high-risk rheumatic heart disease

Scientists reveal toxic astrocyte changes in ALS

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News